相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Peter Atadja
CANCER LETTERS (2009)
Dual Degradation of Aurora A and B Kinases by the Histone Deacetylase Inhibitor LBH589 Induces G2-M Arrest and Apoptosis of Renal Cancer Cells
Tai-Lung Cha et al.
CLINICAL CANCER RESEARCH (2009)
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
Anna Scuto et al.
BLOOD (2008)
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
Henk M. W. Verheul et al.
CLINICAL CANCER RESEARCH (2008)
Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy
Weihua Song et al.
CLINICAL CANCER RESEARCH (2008)
Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans
Lyudmila Lyakh et al.
IMMUNOLOGICAL REVIEWS (2008)
How microorganisms tip the balance between interleukin-12 family members
Stanislas Goriely et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment
Konrad A. Bode et al.
IMMUNOLOGY (2007)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Jennifer L. Brogdon et al.
BLOOD (2007)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
DZ Qian et al.
CLINICAL CANCER RESEARCH (2006)
Understanding the IL-23-IL-17 immune pathway
BS McKenzie et al.
TRENDS IN IMMUNOLOGY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors
Kenya Honda et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Trichostatin A attenuates airway inflammation in mouse asthma model
JH Choi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Going both ways: immune regulation via CD1d-dependent NKT cells
DI Godfrey et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
F Leoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
